The tegument protein pp65 of human cytomegalovirus acts as an optional scaffold protein that optimizes protein uploading into viral particles

Journal of Virology

Volumn 88, Issue 17, 2014, Pages 9633-9646

  Reyda, Sabine ^a   Tenzer, Stefan ^a   Navarro, Pedro ^a   Gebauer, Wolfgang ^b   Saur, Michael ^b   Krauter, Steffi ^a   Büscher, Nicole ^a   Plachter, Bodo ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; MATRIX PROTEIN; PHOSPHOPROTEIN; PROTEOME;

CHEMISTRY; CYTOMEGALOVIRUS; DEFICIENCY; GENE DELETION; GENETICS; HUMAN; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY; VIRION; VIRUS ASSEMBLY;

CYTOMEGALOVIRUS; GENE DELETION; HUMANS; MASS SPECTROMETRY; PHOSPHOPROTEINS; PROTEOME; VIRAL MATRIX PROTEINS; VIRION; VIRUS ASSEMBLY;

EID: 84910609738     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01415-14     Document Type: Article

References (72)

1. Tandon R, Mocarski ES. 2012. Viral and host control of cytomegalovirus maturation. Trends Microbiol. 20:392-401. http://dx.doi.org/10.1016/j.tim.2012.04.008.
2. Gibson W, Bogner E. 2013. Morphogenesis of the cytomegalovirus virion and subviral particles, p 230-246. In Reddehase MJ (ed), Cytomegaloviruses: from molecular pathogenesis to intervention, 2nd ed, vol 1. Caister Academic Press, Norfolk, United Kingdom.
3. Sampaio KL, Cavignac Y, Stierhof YD, Sinzger C. 2005. Human cytomegalovirus labeled with green fluorescent protein for live analysis of intracellular particle movements. J. Virol. 79:2754-2767. http://dx.doi.org/10.1128/JVI.79.5.2754-2767.2005.
4. Sanchez V, Sztul E, Britt WJ. 2000. Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-golgi-intermediate compartment. J. Virol. 74:3842-3851. http://dx.doi.org/10.1128/JVI.74.8.3842-3851.2000.
5. Mettenleiter TC, Klupp BG, Granzow H. 2009. Herpesvirus assembly: an update. Virus Res. 143:222-234. http://dx.doi.org/10.1016/j.virusres.2009.03.018.
6. Marschall M, Feichtinger S, Milbradt J. 2011. Regulatory roles of protein kinases in cytomegalovirus replication. Adv. Virus Res. 80:69-101. http://dx.doi.org/10.1016/B978-0-12-385987-7.00004-X.
7. Cepeda V, Esteban M, Fraile-Ramos A. 2010. Human cytomegalovirus final envelopment on membranes containing both trans-Golgi network and endosomal markers. Cell Microbiol. 12:386-404. http://dx.doi.org/10.1111/j.1462-5822.2009.01405.x.
8. Tandon R, AuCoin DP, Mocarski ES. 2009. Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation. J. Virol. 83:10797-10807. http://dx.doi.org/10.1128/JVI.01093-09.
9. Cepeda V, Fraile-Ramos A. 2011. A role for the SNARE protein syntaxin 3 in human cytomegalovirus morphogenesis. Cell Microbiol. 13:846-858. http://dx.doi.org/10.1111/j.1462-5822.2011.01583.x.
10. Tandon R, Mocarski ES. 2008. Control of cytoplasmic maturation events by cytomegalovirus tegument protein pp150. J. Virol. 82:9433-9444. http://dx.doi.org/10.1128/JVI.00533-08.
11. Yu X, Shah S, Lee M, Dai W, Lo P, Britt W, Zhu H, Liu F, Zhou ZH. 2011. Biochemical and structural characterization of the capsid-bound tegument proteins of human cytomegalovirus. J. Struct. Biol. 174:451-460. http://dx.doi.org/10.1016/j.jsb.2011.03.006.
12. Tavalai N, Stamminger T. 2011. Intrinsic cellular defense mechanisms targeting human cytomegalovirus. Virus Res. 157:128-133. http://dx.doi.org/10.1016/j.virusres.2010.10.002.
13. Kalejta RF. 2008. Functions of human cytomegalovirus tegument proteins prior to immediate early gene expression, p 101-115. In Shenk T, Stinski MF (ed), Human cytomegalovirus, vol 325. Springer, Berlin, Germany.
14. Kalejta RF. 2013. Pre-immediate early tegument protein functions, p 141-151. In Reddehase MJ (ed), Cytomegaloviruses: from molecular pathogenesis to intervention, 2nd ed. Caister Academic Press, Norfolk, United Kingdom.
15. Li T, Chen J, Cristea IM. 2013. Human cytomegalovirus tegument protein pUL83 inhibits IFI16-mediated DNA sensing for immune evasion. Cell Host Microbe 14:591-599. http://dx.doi.org/10.1016/j.chom.2013.10.007.
16. Bogdanow B, Weisbach H, von Straschewski S, Voigt S, Winkler M, Hagemeier C, Wiebusch L. 2013. Human cytomegalovirus tegument protein pp150 acts as a cyclin A2-CDK-dependent sensor of the host cell cycle and differentiation state. Proc. Natl. Acad. Sci. U. S. A. 110:17510-17515. http://dx.doi.org/10.1073/pnas.1312235110.
17. Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, Pasa-Tolic L, Wang D, Camp DG, Rodland K, Wiley S, Britt W, Shenk T, Smith RD, Nelson JA. 2004. Identification of proteins in human cytomegalovirus (HCMV) particles: theHCMVproteome. J. Virol. 78:10960-10966. http://dx.doi.org/10.1128/JVI.78.20.10960-10966.2004.
18. Irmiere A, Gibson W. 1983. Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus. Virology 130:118-133. http://dx.doi.org/10.1016/0042-6822(83)90122-8.
19. Roby C, Gibson W. 1986. Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus. J. Virol. 59:714-727.
20. Cristea IM, Moorman NJ, Terhune SS, Cuevas CD, O'Keefe ES, Rout MP, Chait BT, Shenk T. 2010. Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein. J. Virol. 84:7803-7814. http://dx.doi.org/10.1128/JVI.00139-10.
21. Gilbert MJ, Riddell SR, Plachter B, Greenberg PD. 1996. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature 383:720-722. http://dx.doi.org/10.1038/383720a0.
22. Odeberg J, Plachter B, Branden L, Soderberg-Naucler C. 2003. Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain. Blood 101:4870-4877. http://dx.doi.org/10.1182/blood-2002-05-1504.
23. Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, Gazit R, Gonen-Gross T, Hanna J, Nahari E, Porgador A, Honigman A, Plachter B, Mevorach D, Wolf DG, Mandelboim O. 2005. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat. Immunol. 6:515-523. http://dx.doi.org/10.1038/ni1190.
24. Browne EP, Shenk T. 2003. Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc. Natl. Acad. Sci. U. S. A. 100:11439-11444. http://dx.doi.org/10.1073/pnas.1534570100.
25. Schmolke S, Kern HF, Drescher P, Jahn G, Plachter B. 1995. The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J. Virol. 69:5959-5968.
26. Chevillotte M, Landwehr S, Linta L, Frascaroli G, Luske A, Buser C, Mertens T, von Einem J. 2009. Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages. J. Virol. 83: 2480-2490. http://dx.doi.org/10.1128/JVI.01818-08.
27. Reyda S, Buscher N, Tenzer S, Plachter B. 2014. Proteomic analyses of human cytomegalovirus strain AD169 derivatives reveal highly conserved patterns of viral and cellular proteins in infected fibroblasts. Viruses. 6:172-188. http://dx.doi.org/10.3390/v6010172.
28. Besold K, Frankenberg N, Pepperl-Klindworth S, Kuball J, Theobald M, Hahn G, Plachter B. 2007. Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasion. J. Gen. Virol. 88:1429-1439. http://dx.doi.org/10.1099/vir.0.82686-0.
29. Borst EM, Hahn G, Koszinowski UH, Messerle M. 1999. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J. Virol. 73:8320-8329.
30. Hobom U, Brune W, Messerle M, Hahn G, Koszinowski UH. 2000. Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J. Virol. 74:7720-7729. http://dx.doi.org/10.1128/JVI.74.17.7720-7729.2000.
31. Yu D, Smith GA, Enquist LW, Shenk T. 2002. Construction of a selfexcisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J. Virol. 76:2316-2328. http://dx.doi.org/10.1128/jvi.76.5.2316-2328.2002.
32. Hesse J, Reyda S, Tenzer S, Besold K, Reuter N, Krauter S, Büscher N, Stamminger T, Plachter B. 2013. Human cytomegalovirus pp71 stimulates major histocompatibility complex class I presentation of IE1-derived peptides at immediate early times of infection. J. Virol. 87:5229-5238. http://dx.doi.org/10.1128/JVI.03484-12.
33. Becke S, Fabre-Mersseman V, Aue S, Auerochs S, Sedmak T, Wolfrum U, Strand D, Marschall M, Plachter B, Reyda S. 2010. Modification of the major tegument protein pp65 of human cytomegalovirus inhibits virus growth and leads to the enhancement of a protein complex with pUL69 and pUL97 in infected cells. J. Gen. Virol. 91:2531-2541. http://dx.doi.org/10.1099/vir.0.022293-0.
34. Becke S, Aue S, Thomas D, Schader S, Podlech J, Bopp T, Sedmak T, Wolfrum U, Plachter B, Reyda S. 2010. Optimized recombinant dense bodies of human cytomegalovirus efficiently prime virus specific lymphocytes and neutralizing antibodies without the addition of adjuvant. Vaccine 28:6191-6198. http://dx.doi.org/10.1016/j.vaccine.2010.07.016.
35. Besold K, Wills M, Plachter B. 2009. Immune evasion proteins gpUS2 and gpUS11 of human cytomegalovirus incompletely protect infected cells from CD8 T cell recognition. Virology 391:5-19. http://dx.doi.org/10.1016/j.virol.2009.06.004.
36. Utz U, Britt W, Vugler L, Mach M. 1989. Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. J. Virol. 63: 1995-2001.
37. Liu Y, Biegalke BJ. 2002. The human cytomegalovirus UL35 gene encodes two proteins with different functions. J. Virol. 76:2460-2468. http://dx.doi.org/10.1128/jvi.76.5.2460-2468.2002.
38. Pepperl S, Münster J, Mach M, Harris JR, Plachter B. 2000. Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression. J. Virol. 74:6132-6146. http://dx.doi.org/10.1128/JVI.74.13.6132-6146.2000.
39. Harris JR, Horne RW. 1991. Negative staining, p 203-208. In Harris JR (ed), Electron microscopy in biology. IRL Press, Oxford, England.
40. Kramer-Albers EM, Bretz N, Tenzer S, Winterstein C, Mobius W, Berger H, Nave KA, Schild H, Trotter J. 2007. Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: trophic support for axons? Proteomics Clin. Appl. 1:1446-1461. http://dx.doi.org/10.1002/prca.200700522.
41. Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, Knauer SK, Bantz C, Nawroth T, Bier C, Sirirattanapan J, Mann W, Treuel L, Zellner R, Maskos M, Schild H, Stauber RH. 2011. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano. 5:7155-7167. http://dx.doi.org/10.1021/nn201950e.
42. Stern-Ginossar N, Weisburd B, Michalski A, Le VT, Hein MY, Huang SX, Ma M, Shen B, Qian SB, Hengel H, Mann M, Ingolia NT, Weissman JS. 2012. Decoding human cytomegalovirus. Science 338:1088-1093. http://dx.doi.org/10.1126/science.1227919.
43. Patzig J, Jahn O, Tenzer S, Wichert SP, de Monasterio-Schrader P, Rosfa S, Kuharev J, Yan K, Bormuth I, Bremer J, Aguzzi A, Orfaniotou F, Hesse D, Schwab MH, Mobius W, Nave KA, Werner HB. 2011. Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci. J. Neurosci. 31:16369-16386. http://dx.doi.org/10.1523/JNEUROSCI.4016-11.2011.
44. Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ. 2006. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol. Cell. Proteomics 5:144-156. http://dx.doi.org/10.1074/mcp.M500230-MCP200.
45. Distler U, Kuharev J, Navarro P, Levin Y, Schild H, Tenzer S. 2014. Drift time-specific collision energies enable deep-coverage dataindependent acquisition proteomics. Nat. Methods 11:167-170. http://dx.doi.org/10.1038/nmeth.2767.
46. Ahrne E, Molzahn L, Glatter T, Schmidt A. 2013. Critical assessment of proteome-wide label-free absolute abundance estimation strategies. Proteomics 13:2567-2578. http://dx.doi.org/10.1002/pmic.201300135.
47. Chen DH, Jiang H, Lee M, Liu F, Zhou ZH. 1999. Three-dimensional visualization of tegument/capsid interactions in the intact human cytomegalovirus. Virology 260:10-16. http://dx.doi.org/10.1006/viro.1999.9791.
48. Mocarski ES, Shenk T, Pass RF. 2007. Cytomegaloviruses, p 2701-2772. In Knipe DM, Howley PM (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
49. Caposio P, Streblow DN, Nelson JA. 2013. Cytomegalovirus proteomics, p 86-108. In Reddehase MJ (ed), Cytomegaloviruses from molecular pathogenesis to intervention, 2nd ed, vol 1. Caister Academic Press, Norfolk, United Kingdom.
50. Huber MT, Compton T. 1998. The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex. J. Virol. 72:8191-8197.
51. Zhou M, Yu Q, Wechsler A, Ryckman BJ. 2013. Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH/gL/gO and gH/gL/UL128-131 in the virion envelope. J. Virol. 87:9680-9690. http://dx.doi.org/10.1128/JVI.01167-13.
52. Mocarski ES, Shenk T, Griffiths PD, Pass RF. 2013. Cytomegaloviruses, p 1960-2014. In Knipe DM, Howley PM (ed), Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
53. Zhao J, Meyerkord CL, Du Y, Khuri FR, Fu H. 2011. 14-3-3 proteins as potential therapeutic targets. Semin. Cell Dev. Biol. 22:705-712. http://dx.doi.org/10.1016/j.semcdb.2011.09.012.
54. Wright JF, Kurosky A, Pryzdial EL, Wasi S. 1995. Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts. J. Virol. 69:4784-4791.
55. Michelson S, Turowski P, Picard L, Goris J, Landini MP, Topilko A, Hemmings B, Bessia C, Garcia A, Virelizier JL. 1996. Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A. J. Virol. 70:1415-1423.
56. Baldick CJ, Jr, Shenk T. 1996. Proteins associated with purified human cytomegalovirus particles. J. Virol. 70:6097-6105.
57. Malouli D, Hansen SG, Nakayasu ES, Marshall EE, Hughes CM, Ventura AB, Gilbride RM, Lewis MS, Xu G, Kreklywich C, Whizin N, Fischer M, Legasse AW, Viswanathan K, Siess D, Camp DG, Axthelm MK, Kahl C, Defilippis VR, Smith RD, Streblow DN, Picker LJ, Fruh K. 2014. Cytomegalovirus pp65 limits dissemination but is dispensable for persistence. J. Clin. Invest. 124:1928-1944. http://dx.doi.org/10.1172/JCI67420.
58. Loret S, Guay G, Lippe R. 2008. Comprehensive characterization of extracellular herpes simplex virus type 1 virions. J. Virol. 82:8605-8618. http://dx.doi.org/10.1128/JVI.00904-08.
59. Zhu FX, Chong JM, Wu L, Yuan Y. 2005. Virion proteins of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79:800-811. http://dx.doi.org/10.1128/JVI.79.2.800-811.2005.
60. Kramer T, Greco TM, Enquist LW, Cristea IM. 2011. Proteomic characterization of pseudorabies virus extracellular virions. J. Virol. 85:6427-6441. http://dx.doi.org/10.1128/JVI.02253-10.
61. Johannsen E, Luftig M, Chase MR, Weicksel S, Cahir-McFarland E, Illanes D, Sarracino D, Kieff E. 2004. Proteins of purified Epstein-Barr virus. Proc. Natl. Acad. Sci. U. S. A. 101:16286-16291. http://dx.doi.org/10.1073/pnas.0407320101.
62. Stegen C, Yakova Y, Henaff D, Nadjar J, Duron J, Lippe R. 2013. Analysis of virion-incorporated host proteins required for herpes simplex virus type 1 infection through a RNA interference screen. PLoS One 8:e53276. http://dx.doi.org/10.1371/journal.pone.0053276.
63. Bechtel JT, Winant RC, Ganem D. 2005. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79:4952-4964. http://dx.doi.org/10.1128/JVI.79.8.4952-4964.2005.
64. Dry I, Haig DM, Inglis NF, Imrie L, Stewart JP, Russell GC. 2008. Proteomic analysis of pathogenic and attenuated alcelaphine herpesvirus 1. J. Virol. 82:5390-5397. http://dx.doi.org/10.1128/JVI.00094-08.
65. Lippe R. 2012. Deciphering novel host-herpesvirus interactions by virion proteomics. Front. Microbiol. 3:181. http://dx.doi.org/10.3389/fmicb.2012.00181.
66. Kattenhorn LM, Mills R, Wagner M, Lomsadze A, Makeev V, Borodovsky M, Ploegh HL, Kessler BM. 2004. Identification of proteins associated with murine cytomegalovirus virions. J. Virol. 78:11187-11197. http://dx.doi.org/10.1128/JVI.78.20.11187-11197.2004.
67. Alwine JC. 2008. Modulation of host cell stress responses by human cytomegalovirus, p 263-279. In Shenk T, Stinski MF (ed), Human cytomegalovirus, vol 325. Springer, Berlin, Germany.
68. Zenner HL, Yoshimura S, Barr FA, Crump CM. 2011. Analysis of Rab GTPase-activating proteins indicates that Rab1a/b and Rab43 are important for herpes simplex virus 1 secondary envelopment. J. Virol. 85:8012-8021. http://dx.doi.org/10.1128/JVI.00500-11.
69. Indran SV, Britt WJ. 2011. A role for the small GTPase Rab6 in assembly of human cytomegalovirus. J. Virol. 85:5213-5219. http://dx.doi.org/10.1128/JVI.02605-10.
70. Stenmark H. 2009. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell. Biol. 10:513-525. http://dx.doi.org/10.1038/nrm2728.
71. To A, Bai Y, Shen A, Gong H, Umamoto S, Lu S, Liu F. 2011. Yeast two hybrid analyses reveal novel binary interactions between human cytomegalovirus-encoded virion proteins. PLoS One 6:e17796. http://dx.doi.org/10.1371/journal.pone.0017796.
72. Phillips SL, Bresnahan WA. 2011. Identification of binary interactions between human cytomegalovirus virion proteins. J. Virol. 85:440-447. http://dx.doi.org/10.1128/JVI.01551-10.